Oncaspar OverviewPegaspargase /pæsprez/, trade name Oncaspar, is a modified enzyme used as an antineoplastic agent. It is a form of L-asparaginase which has undergone PEGylation. The drug is manufactured by Exelead, Inc. It is used in the treatment of acute lymphoblastic leukemia. It is on the World Health Organization's List of Essential Medicines, the safest and most effective medicines needed in a health system. See also P...
Read more Oncaspar Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pegaspargase
Recent Oncaspar Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 750IU/ml
- Vial: 750iu/vial
NDC Database Records for Oncaspar: (2 results)Sorted by National Drug Code
- 0944-3810 Oncaspar 750 [Iu]/Ml Intramuscular; Intravenous Injection, Solution by Baxalta Us Inc.
- 54482-301 Oncaspar 750 [iu]/Ml Intramuscular; Intravenous Injection, Solution by Sigma-tau Pharmaceuticals, Inc.